Sana Biotechnology, Inc. Depreciation in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sana Biotechnology, Inc. quarterly/annual Depreciation history and growth rate from 2019 to Q3 2025.
  • Sana Biotechnology, Inc. Depreciation for the quarter ending September 30, 2025 was $3.2M, a 22% decline year-over-year.
  • Sana Biotechnology, Inc. Depreciation for the twelve months ending September 30, 2025 was $15.4M, a 33.2% decline year-over-year.
  • Sana Biotechnology, Inc. annual Depreciation for 2024 was $17.4M, a 29.3% decline from 2023.
  • Sana Biotechnology, Inc. annual Depreciation for 2023 was $24.6M, a 57.7% increase from 2022.
  • Sana Biotechnology, Inc. annual Depreciation for 2022 was $15.6M, a 40.5% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Sana Biotechnology, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $15.4M $3.2M -$900K -22% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $16.3M $2.9M -$1M -25.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $17.3M $3.65M -$97K -2.59% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $17.4M $5.65M -$5.65M -50% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-17
Q3 2024 $23M $4.1M -$400K -8.89% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $23.4M $3.9M -$600K -13.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $24M $3.75M -$554K -12.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $24.6M $11.3M +$7.11M +170% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-17
Q3 2023 $17.5M $4.5M +$500K +12.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $17M $4.5M +$700K +18.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $16.3M $4.3M +$686K +19% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $15.6M $4.19M +$733K +21.2% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-17
Q3 2022 $14.9M $4M +$1.2M +42.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $13.7M $3.8M +$1.2M +46.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $12.5M $3.61M +$1.37M +60.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $11.1M $3.45M +$1.8M +109% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $9.3M $2.8M +$1.2M +75% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $8.1M $2.6M +$1.2M +85.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $6.9M $2.25M +$982K +77.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $5.92M $1.66M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 $1.6M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $1.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.27M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05

Sana Biotechnology, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $17.4M -$7.2M -29.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $24.6M +$9M +57.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $15.6M +$4.5M +40.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $11.1M +$5.18M +87.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $5.92M +$4.1M +224% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $1.83M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.